Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies

Diabetologia

Volumn 58, Issue 5, 2015, Pages 900-911

  Zhu, Hongmei ^a   Leung, Siu Wai ^a,b  

^a University of Macau   (Macao)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Meta analysis; MicroRNA; Type 2 diabetes

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

GENE EXPRESSION PROFILING; GENETICS; HUMAN; META ANALYSIS; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS;

BIOMARKERS; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION PROFILING; HUMANS; MICRORNAS;

EID: 84934777883     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3510-2     Document Type: Article

References (82)

1. Kahn SE (2001) Clinical review 135: the importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 86:4047–4058
2. Karolina DS, Armugam A, Sepramaniam S, Jeyaseelan K (2012) MiRNAs and diabetes mellitus. Expert Rev Endocrinol Metab 7:281–300
3. Winer N, Sowers JR (2004) Epidemiology of diabetes. J Clin Pharmacol 44:397–405
4. Shantikumar S, Caporali A, Emanueli C (2012) Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc Res 93:583–593
5. Carrington JC, Ambros V (2003) Role of microRNAs in plant and animal development. Science 301:336–338
6. Suárez Y, Sessa WC (2009) MicroRNAs as novel regulators of angiogenesis. Circ Res 104:442–454
7. Van Rooij E, Olson EN (2011) Modulation of K-ras-dependent lung tumorigenesis by microRNA-21. Cancer Cell 18:282–293
8. Fabian MR, Sonenberg N, Filipowicz W (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79:351–379
9. Bagge A, Clausen TR, Larsen S et al (2012) MicroRNA-29a is up-regulated in beta-cells by glucose and decreases glucose-stimulated insulin secretion. Biochem Biophys Res Commun 426:266–272
10. Locke JM, Harries LW (2012) MicroRNA expression profiling of human islets from individuals with and without type 2 diabetes: promises and pitfalls. Biochem Soc Trans 40:800–803
11. Karolina DS, Tavintharan S, Armugam A et al (2012) Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab 97:E2271–E2276
12. Liu J, Liu W, Ying H et al (2012) Analysis of microRNA expression profile induced by AICAR in mouse hepatocytes. Gene 512:364–372
13. Prinz F, Schlange T, Asadullah K (2011) Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov 10:712
14. Begley CG, Ellis LM (2012) Raise standards for preclinical cancer research. Nature 483:531–533
15. Mobley A, Linder SK, Braeuer R et al (2013) A survey on data reproducibility in cancer research provides insights into our limited ability to translate findings from the laboratory to the clinic. PLoS One 8:e63221
16. Guay C, Roggli E, Nesca V et al (2011) Diabetes mellitus, a microRNA-related disease? Transl Res 157:253–264
17. Guay C, Jacovetti C, Nesca V (2012) Emerging roles of non-coding RNAs in pancreatic β-cell function and dysfunction. Diabetes Obes Metab 14:12–21
18. Hamar P (2012) Role of regulatory microRNAs in type 2 diabetes mellitus related inflammation. Nucleic Acid Ther 22:289–294
19. McClelland AD, Kantharidis P (2014) MicroRNA in the development of diabetic complications. Clin Sci (Lond) 126:95–110
20. Natarajan R, Putta S, Kato M (2012) MicroRNAs and diabetic complications. J Cardiovasc Transl Res 5:413–422
21. Park N, Zhou H, Elashoff D (2009) Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 15:5473–5477
22. Hanke M, Hoefig K, Merz H et al (2010) A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol 28:655–661
23. Weber JA, Baxter DH, Zhang S et al (2010) The microRNA spectrum in 12 body fluids. Clin Chem 56:1733–1741
24. Yamada Y, Enokida H, Kojima S et al (2011) MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology. Cancer Sci 102:522–529
25. The Functional Genomics Data Society (1991) Minimum information about a microarray experiment - MIAME 2.0. Available from www.mged.org/Workgroups/MIAME/miame_2.0.html. Accessed 26 Apr 2007
26. Bustin SA, Benes V, Garson JA et al (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611–622
27. Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36:1–48
28. Balasubramanyam M, Aravind S, Gokulakrishnan K et al (2011) Impaired miR-146a expression links subclinical inflammation and insulin resistance in type 2 diabetes. Mol Cell Biochem 351:197–205
29. Corral-Fernández NE, Salgado-Bustamante M, Martínez-Leija ME et al (2013) Dysregulated miR-155 expression in peripheral blood mononuclear cells from patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 121:347–353
30. Gallagher IJ, Scheele C, Keller P et al (2010) Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med 2:9
31. Karolina DS, Armugam A, Tavintharan S et al (2011) MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS One 6:e22839
32. Klöting N, Berthold S, Kovacs P et al (2009) MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS One 4:e4699
33. Kong L, Han W, Jiang X et al (2010) Expression and clinical significance of peripheral miR-34a during the onset of type 2 diabetes. J Shangdong Univ Health Sci 48:2–4
34. Kong L, Zhu J, Han W et al (2011) Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol 48:61–69
35. Locke JM, da Silva Xavier G, Dawe HR et al (2014) Increased expression of miR-187 in human islets from individuals with type 2 diabetes is associated with reduced glucose-stimulated insulin secretion. Diabetologia 57:122–128
36. Lu H, Buchan RJ, Cook SA (2010) MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovasc Res 86:410–420
37. Meng S, Cao J-T, Zhang B et al (2012) Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients impairs their functional properties via target gene Spred-1. J Mol Cell Cardiol 53:64–72
38. Ortega FJ, Moreno-Navarrete JM, Pardo G et al (2010) MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation. PLoS One 5:e9022
39. Ortega FJ, Mercader JM, Moreno-Navarrete JM et al (2014) Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization. Diabetes Care 37:1375–1383
40. Pescador N, Pérez-Barba M, Ibarra JM et al (2013) Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers. PLoS One 8:e77251
41. Rong Y, Bao W, Shan Z et al (2013) Increased microRNA-146a levels in plasma of patients with newly diagnosed type 2 diabetes mellitus. PLoS One 8:e73272
42. Spinetti G, Fortunato O, Caporali A et al (2013) MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia. Circ Res 112:335–346
43. Sun K, Chang X, Yin L et al (2014) Expression and DNA methylation status of microRNA-375 in patients with type 2 diabetes mellitus. Mol Med Rep 9:967–972
44. Wang H, Lin Y, Zhou Y et al (2012) Circulatory level of microRNA 92a in patients of stable angina pectoris with diabetes mellitus. China J Mod Med 22:26–29
45. Wang X, Sundquist J, Zöller B et al (2014) Determination of 14 circulating microRNAs in Swedes and Iraqis with and without type 2 diabetes mellitus. PLoS One 9:e86792
46. Zampetaki A, Kiechl S, Drozdov I et al (2010) Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107:810–817
47. Zhang T, Lv C, Li L et al (2013) Plasma miR-126 is a potential biomarker for early prediction of type 2 diabetes mellitus in susceptible individuals. Biomed Res Int 2013:761617
48. Zhao H, Guan J, Lee H-M et al (2010) Up-regulated pancreatic tissue microRNA-375 associates with human type 2 diabetes through beta-cell deficit and islet amyloid deposition. Pancreas 39:843–846
49. Zhou J, Peng R, Li T et al (2013) A potentially functional polymorphism in the regulatory region of let-7a-2 is associated with an increased risk for diabetic nephropathy. Gene 527:456–461
50. Chettimada S, Ata H, Rawat DK et al (2014) Contractile protein expression is upregulated by reactive oxygen species in aorta of Goto-Kakizaki rat. Am J Physiol Heart Circ Physiol 306:H214–H224
51. Esguerra JLS, Bolmeson C, Cilio CM, Eliasson L (2011) Differential glucose-regulation of microRNAs in pancreatic islets of non-obese type 2 diabetes model Goto-Kakizaki rat. PLoS One 6:e18613
52. He A, Zhu L, Gupta N et al (2007) Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol 21:2785–2794
53. Herrera BM, Lockstone HE, Taylor JM et al (2009) MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of type 2 diabetes. BMC Med Genomics 2:54
54. Herrera BM, Lockstone HE, Taylor JM et al (2010) Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia 53:1099–1109
55. Jordan SD, Krüger M, Willmes DM et al (2011) Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol 13:434–446
56. Kato M, Putta S, Wang M et al (2009) TGF-β activates Akt kinase via a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 11:881–889
57. Kato M, Wang L, Putta S et al (2010) Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-β-induced collagen expression in kidney cells. J Biol Chem 285:34004–34015
58. Kaur K, Pandey AK, Srivastava S et al (2011) Comprehensive miRNome and in silico analyses identify the Wnt signaling pathway to be altered in the diabetic liver. Mol Biosyst 7:3234–3244
59. Lovis P, Roggli E, Laybutt DR et al (2008) Alterations in microRNA expression contribute to fatty acid-induced pancreatic β-cell dysfunction. Diabetes 57:2728–2736
60. Nesca V, Guay C, Jacovetti C et al (2013) Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes. Diabetologia 56:2203–2212
61. Poy MN, Hausser J, Trajkovski M et al (2009) MiR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci U S A 106:5813–5818
62. Trajkovski M, Hausser J, Soutschek J et al (2011) MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474:649–653
63. Suvh M, Villeneuve LM, Kato M et al (2010) Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone. Diabetes 59:2904–2915
64. Zhang Z, Peng H, Chen J et al (2009) MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. FEBS Lett 583:2009–2014
65. Gilad S, Meiri E, Yogev Y et al (2008) Serum microRNAs are promising novel biomarkers. PLoS One 3:e3148
66. Laterza OF, Lim L, Garrett-Engele PW et al (2009) Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 55:1977–1983
67. Kosaka N, Iguchi H, Yoshioka Y et al (2010) Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285:17442–17452
68. Cho WCS (2011) Circulating microRNAs as minimally invasive biomarkers for cancer theragnosis and prognosis. Front Genet 2:1–6
69. Chen X, Ba Y, Ma L et al (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18:997–1006
70. Roggli E, Britan A, Gattesco S et al (2010) Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic β-cells. Diabetes 59:978–986
71. Poy MN, Eliasson L, Krutzfeldt J et al (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432:226–230
72. El Ouaamari A, Baroukh N, Martens GA et al (2008) MiR-375 targets 3-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic β-cells. Diabetes 57:2708–2717
73. Chartoumpekis DV, Zaravinos A, Ziros PG et al (2012) Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice. PLoS One 7:e34872
74. Yun S-J, Kim E-K, Tucker DF et al (2008) Isoform-specific regulation of adipocyte differentiation by Akt/protein kinase B alpha. Biochem Biophys Res Commun 371:138–143
75. Shukla U, Tumma N, Gratsch T et al (2013) Insights into insulin-mediated regulation of CYP2E1: miR-132/-212 targeting of CYP2E1 and role of phosphatidylinositol 3-kinase, Akt (protein kinase B), mammalian target of rapamycin signaling in regulating miR-132/-212 and miR-122/-181a expression in primary cultured rat hepatocytes. Drug Metab Dispos 41:1769–1777
76. Choe N, Kwon J-S, Kim J-R et al (2013) The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia. Atherosclerosis 229:348–355
77. Su Z, Si W, Li L et al (2014) MiR-144 regulates hematopoiesis and vascular development by targeting meis1 during zebrafish development. Int J Biochem Cell Biol 49:53–63
78. Kriegel AJ, Liu Y, Fang Y et al (2012) The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury. Physiol Genomics 44:237–244
79. Raitoharju E, Lyytikäinen L-P, Levula M et al (2011) MiR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 219:211–217
80. Min HK, Kapoor A, Fuchs M et al (2013) Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty disease. Cell Metab 15:665–674
81. Chen B, Li H, Zeng X et al (2012) Roles of microRNA on cancer cell metabolism. J Transl Med 10:228
82. Kinoshita T, Hanazawa T, Nohata N et al (2012) The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways. J Hum Genet 57:556–563